MDCX stock news · Medicus Pharma
Get alerts for MDCX
Follow Medicus Pharma (MDCX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MDCXMedicus Pharma will show off its cancer treatment projects at the BIO-Europe 2026 conference.
NeutralMedicus Pharma will present its drug programs at BIO-Europe in Cologne from November 9–11, 2026. No new trial result or signed deal is reported, so its outlook is unchanged.
Medicus Pharma lost $15.2 million last quarter and shared updates on its plans, including a deal with Pfizer.
NeutralMedicus Pharma reported a $15.2 million third-quarter loss, a SkinJect proposal valued at about $135 million, and restored Nasdaq compliance. These mixed updates do not clearly change its outlook.
Medicus Pharma Ltd. changes rules for its shareholders.
NeutralMedicus Pharma turned every 50 shares into 1 on October 12. Shareholder rights stayed the same, so this filing does not change the company's business outlook.
Medicus Pharma (MDCX) stock dropped 24% after hours because of a big share change coming soon.
NeutralMedicus Pharma will combine 50 shares into 1 to address Nasdaq’s minimum share-price rule. It may help keep its listing, but the story reports no change to its business.
12 health care companies saw big changes in their stock prices after the market closed on Wednesday.
NeutralMedicus Pharma shares fell 30.0% to $0.11 after hours, but the roundup gives no company news, so its business outlook is unchanged.
Medicus Pharma Ltd. will combine every fifty shares into one starting October 12, 2026.
NeutralMedicus Pharma will combine 50 shares into 1 to try to meet Nasdaq's minimum bid-price rule. The change does not alter owners' rights or voting power, so it does not show a business change.
Medicus Pharma Ltd. and Yorkville have agreed to end their money deal starting September 11, 2026.
NeutralMedicus Pharma ended its $15.0 million standby deal with Yorkville, but had no borrowings and Yorkville stays as sales agent, leaving the company's funding picture unchanged.
Thursday's intraday session sees significant fluctuations in 12 health care stocks.
Bad for MDCXShares declined 33.63% intraday, indicating a materially unfavorable near-term move.